Good stuff Joe. I know she is limited to what she can say, but her first response about the meeting being “regarding avenues to advance in a registrational trial” makes it sound like going to phase III. But maybe it will be the required confirmatory trial for accelerated approval. Again, I think it looks good. Put together the PFS with OS and the biomarkers showing the effects and the negligible toxicity. FDA targeting drugs in high unmet needs. I guess we have to wait and see. I am concerned maybe something got leaked that they didn’t get AA and are moving forward with a standard PHIII is what is tanking our investment. Butt I wait…
- Forums
- ASX - By Stock
- Merck conundrum
IMM
immutep limited
Add to My Watchlist
2.04%
!
25.0¢

Good stuff Joe. I know she is limited to what she can say, but...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
25.0¢ |
Change
0.005(2.04%) |
Mkt cap ! $357.7M |
Open | High | Low | Value | Volume |
25.0¢ | 25.0¢ | 25.0¢ | $16.39K | 65.58K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
20 | 498602 | 24.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
25.0¢ | 100790 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
18 | 441686 | 0.245 |
13 | 288125 | 0.240 |
8 | 433765 | 0.235 |
16 | 357481 | 0.230 |
11 | 312677 | 0.225 |
Price($) | Vol. | No. |
---|---|---|
0.250 | 98397 | 8 |
0.255 | 78868 | 10 |
0.260 | 759425 | 10 |
0.265 | 489020 | 6 |
0.270 | 41600 | 3 |
Last trade - 10.04am 17/06/2025 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |
The Watchlist
RC1
REDCASTLE RESOURCES LIMITED
Ronald Miller, Non-Executive Director
Ronald Miller
Non-Executive Director
SPONSORED BY The Market Online